Rohto Pharmaceutical Co (MEX:4527N) Beneish M-Score: -2.47 (As of Jul. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:4527N Rohto Pharmaceutical Co Ltd MEX:4527N
89 GF Score
Price MXN305.75
GF Value MXN428.89
! 2 Warning Signs
View Full Analysis

What is Rohto Pharmaceutical Co Beneish M-Score?

Rohto Pharmaceutical Co MEX:4527N 89 Beneish M-Score is -2.47 as of Jul. 22, 2026. GuruFocus rates MEX:4527N with a GF Score™ of 89/100 and a GF Value™ of MXN428.89. The stock has 2 warning signs investors should review. Among 1,850 Consumer Packaged Goods companies, Rohto Pharmaceutical Co ranks worse than 54.65% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.47 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Rohto Pharmaceutical Co's Beneish M-Score or its related term are showing as below:

MEX:4527N' s Beneish M-Score Range Over the Past 10 Years
Min: -2.92   Med: -2.48   Max: -2.31
Current: -2.47

During the past 13 years, the highest Beneish M-Score of Rohto Pharmaceutical Co was -2.31. The lowest was -2.92. And the median was -2.48.


Rohto Pharmaceutical Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Rohto Pharmaceutical Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rohto Pharmaceutical Co Beneish M-Score Chart

Rohto Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.56 -2.35 -2.39 -2.31 -2.47

Rohto Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.31 0.00 0.00 0.00 -2.47

MEX:4527N vs PG, CL, KVUE: Beneish M-Score Comparison

For the Household & Personal Products subindustry, Rohto Pharmaceutical Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rohto Pharmaceutical Co Beneish M-Score vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Rohto Pharmaceutical Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Rohto Pharmaceutical Co's Beneish M-Score falls into.


MEX:4527N
89GF Score
Rohto Pharmaceutical Co Ltd MEX:4527N
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rohto Pharmaceutical Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Rohto Pharmaceutical Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0037+0.528 * 1.0079+0.404 * 1.0729+0.892 * 0.9221+0.115 * 0.8144
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9774+4.679 * -0.027875-0.327 * 0.9485
=-2.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was MXN5,987 Mil.
Revenue was MXN39,061 Mil.
Gross Profit was MXN21,898 Mil.
Total Current Assets was MXN27,191 Mil.
Total Assets was MXN55,203 Mil.
Property, Plant and Equipment(Net PPE) was MXN10,570 Mil.
Depreciation, Depletion and Amortization(DDA) was MXN1,975 Mil.
Selling, General, & Admin. Expense(SGA) was MXN7,114 Mil.
Total Current Liabilities was MXN13,336 Mil.
Long-Term Debt & Capital Lease Obligation was MXN4,034 Mil.
Net Income was MXN3,892 Mil.
Gross Profit was MXN0 Mil.
Cash Flow from Operations was MXN5,431 Mil.
Total Receivables was MXN6,468 Mil.
Revenue was MXN42,359 Mil.
Gross Profit was MXN23,935 Mil.
Total Current Assets was MXN29,904 Mil.
Total Assets was MXN59,984 Mil.
Property, Plant and Equipment(Net PPE) was MXN12,414 Mil.
Depreciation, Depletion and Amortization(DDA) was MXN1,826 Mil.
Selling, General, & Admin. Expense(SGA) was MXN7,893 Mil.
Total Current Liabilities was MXN12,985 Mil.
Long-Term Debt & Capital Lease Obligation was MXN6,914 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(5987.009 / 39060.905) / (6468.469 / 42358.873)
=0.153274 / 0.152706
=1.0037

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(23935.491 / 42358.873) / (21897.857 / 39060.905)
=0.565064 / 0.560608
=1.0079

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (27191.094 + 10569.769) / 55203.01) / (1 - (29903.958 + 12414.427) / 59983.733)
=0.315964 / 0.294502
=1.0729

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=39060.905 / 42358.873
=0.9221

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1825.566 / (1825.566 + 12414.427)) / (1974.722 / (1974.722 + 10569.769))
=0.1282 / 0.157417
=0.8144

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(7114.09 / 39060.905) / (7892.716 / 42358.873)
=0.182128 / 0.18633
=0.9774

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((4034.447 + 13335.539) / 55203.01) / ((6913.847 + 12984.976) / 59983.733)
=0.314657 / 0.331737
=0.9485

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(3891.829 - 0 - 5430.628) / 55203.01
=-0.027875

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Rohto Pharmaceutical Co has a M-score of -2.64 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.47 mean?
Rohto Pharmaceutical Co (MEX:4527N) has a Beneish M-Score of -2.47 as of Jul. 22, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Rohto Pharmaceutical Co and its competitors. According to the industry distribution chart, Rohto Pharmaceutical Co ranks #1011 out of 1850 companies in the Consumer Packaged Goods industry, placing it in the top 54.6%.
Is Rohto Pharmaceutical Co's Beneish M-Score too high?
Rohto Pharmaceutical Co's current Beneish M-Score is -2.47. Based on the distribution chart, Rohto Pharmaceutical Co ranks #1011 out of 1850 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Rohto Pharmaceutical Co has a GF Score™ of 89/100, reflecting its overall financial health beyond just this single metric.
How does Rohto Pharmaceutical Co's Beneish M-Score compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Rohto Pharmaceutical Co ranks #1011 out of 1850 companies for Beneish M-Score. This places Rohto Pharmaceutical Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Consumer Packaged Goods company?
A good Beneish M-Score depends on the Consumer Packaged Goods industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Rohto Pharmaceutical Co and its competitors. Rohto Pharmaceutical Co's current Beneish M-Score is -2.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rohto Pharmaceutical Co stock overvalued right now?
Rohto Pharmaceutical Co (MEX:4527N) has a current Beneish M-Score of -2.47. The stock's GF Value™ is MXN428.89, compared to a current price of MXN305.75 — trading 28.7% below its estimated fair value. The current Beneish M-Score is -2.47. Rohto Pharmaceutical Co's overall GF Score™ is 89/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Rohto Pharmaceutical Co (MEX:4527N), the current Beneish M-Score is -2.47 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rohto Pharmaceutical Co (MEX:4527N) Overvalued in 2026?

Based on GuruFocus' analysis, Rohto Pharmaceutical Co stock appears to be undervalued. The current stock price of MXN305.75 is trading 28.7% below its estimated GF Value™ of MXN428.89.

Key valuation signals for MEX:4527N:

  • Beneish M-Score: -2.47
  • GF Value™: MXN428.89 vs. price of MXN305.75 (28.7% below fair value)
  • GF Score™: 89/100 with 2 warning signs

No single metric tells the full story. See the MEX:4527N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Rohto Pharmaceutical Co Business Description

Address 1-8-1 Tatsuminishi, Ikuno-ku, Osaka, JPN, 544-8666
Rohto Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of health and beauty care products. The company operates through four reportable segments: Japan, America, Europe, and Asia. Each segment manufactures and sells products related to eye care (such as eye drops and eyewash), skin care (including dermatological medications, lip balm, sunscreen, and functional cosmetics), oral medication (such as gastrointestinal and herbal medicines, and supplements), and other products such as in-vitro diagnostic reagents. It generates the majority of its revenue from Japan.
89GF Score

Get the complete analysis for MEX:4527N

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN305.75
Price
MXN428.89
GF Value